---
title: "Trulicity (dulaglutide) in type 2 diabetes: Guidelines questions"
description: "Guidelines questions on Trulicity (dulaglutide) in type 2 diabetes, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: Trulicity and ADA guidelines: are GLP-1 RAs preferred over insulin? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/guidelines"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T16:49:54-05:00"
---

# Trulicity (dulaglutide) in type 2 diabetes: Guidelines questions

Manufacturer: Eli Lilly and Company  
Prescribing information: [Trulicity](https://uspl.lilly.com/trulicity/trulicity.html#pi)

Questions that apply to every indication of Trulicity are on [Trulicity (dulaglutide), all indications](https://www.evicenter.com/medical-information/trulicity).

## Guidelines

<a id="trulicity-ada-guideline"></a>

### Trulicity and ADA guidelines: are GLP-1 RAs preferred over insulin?

Applies to: Glycemic control as an adjunct to diet and exercise in adults with type 2 diabetes mellitus

> “According to the 2023 ADA Standards of Medical Care, in most adults with type 2 diabetes needing injectable therapy to lower A1C, GLP-1 RAs are preferred to insulin when possible.<sup>*,†</sup>
>
> The full ADA Standards of Medical Care should be reviewed when making treatment decisions for adult patients with type 2 diabetes.<sup>5</sup>
>
> <sup>*</sup>Consider insulin as the first injectable when:
>
> There is evidence of ongoing catabolism
> Symptoms of hyperglycemia are present
> When A1C (>10%) or blood glucose levels (>=300 mg/dL) are very high
> Diagnosis of type 1 diabetes is a possiblity”

Source: [TRULICITY: How Trulicity Works, MOA & FPG and PPG Reductions | HCP, captured 2026-11-13](https://trulicity.lilly.com/hcp/how-trulicity-works#:~:text=According%20to%20the%202023%20ADA,1%20diabetes%20is%20a%20possiblity)

> “<sup>†</sup> When selecting a GLP-1 RA, consider:
>
> Patient preference
> A1C lowering
> Weight-lowering effect
> Frequency of injection”

Source: [TRULICITY: How Trulicity Works, MOA & FPG and PPG Reductions | HCP, captured 2026-11-13](https://trulicity.lilly.com/hcp/how-trulicity-works#:~:text=When%20selecting%20a%20GLP%2D1%20RA%2C,Frequency%20of%20injection)

Note: This is the manufacturer's summary of the 2023 American Diabetes Association Standards of Care on the How Trulicity Works page; the statement concerns GLP-1 receptor agonists as a class. The ADA publishes a revised edition of the Standards each year, and the current edition governs.

## Related pages
- [Medical information: Trulicity (dulaglutide): Type 2 diabetes](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes)
- [Indication](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/safety)
- [Specific populations](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/trulicity--type-2-diabetes/access-and-coverage)
